Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in a variety of clinical symptoms ranging from no or mild to severe disease. Currently, there are multiple postulated mechanisms that may push a moderate to severe disease into a critical state. Human serum contains abunda...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Amanda J. Griffin, Kyle L. O’Donnell, Kyle Shifflett, John-Paul Lavik, Patrick M. Russell, Michelle K. Zimmerman, Ryan F. Relich, Andrea Marzi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2022-03-01
coleção:	Scientific Reports
Acesso em linha:	https://doi.org/10.1038/s41598-022-07960-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!